By Pushkala Aripaka (Reuters) -Sensodyne toothpaste maker Haleon on Thursday forecast high single-digit percentage growth in its profit from 2026, helped by steady demand for its products in key ...

Newell Brands has not changed its current financial forecast for the year ... despite the clouded outlook for the American ...

The Elton John AIDS Foundation is delighted to announce the appointment of three new members to its Board of Directors - ...

On Jan. 20, 2025, Donald Trump was sworn into his second term as president. His administration has ushered in significant changes to the leadership, policies, operations, and funding of federal ...

I run several special projects including the Readers' Choice and Business Choice surveys, and yearly coverage of the Best ISPs and Best Gaming ISPs, plus Best Products of the Year and Best Brands.

Discover the top restaurant logos for design inspiration. Get ideas to create a standout brand identity for your business. Perfect for business owners. Logos are an essential part of a restaurant's ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.00. The company’s shares closed today ...

Talented vocalists also energized guests with a vibrant performance of HKDL’s brand-new 20th anniversary ... forming the signature 20th anniversary logo alongside the Castle of Magical Dreams ...

“I can’t think of another brand that is present everywhere, so that must have an influence on our daily cars. If we’re not doing that, we are making the wrong investments. So it’s got to ...

MOVE OVER, CHINA — China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines ... 1 meningococcal vaccine by GSK for some people who would ...

Monday in golf belonged to Jordan Brand, a subsidiary of Nike that operates as its own apparel entity, which announced its return to the golf space. Its launch focused on the unveiling of the ...

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is approved for the treatment of adults with multiple myeloma ...